Global Opisthorchiasis Treatment Market is driven by increasing demand for effective treatment for infectious diseases in the forecast period, 2023-2027.
Increased consumption of seafood in raw form further increases the risks of the infection spread thus supports the growth of the global opisthorchiasis treatment market in the next five years. Vigorous research toward early diagnosis and effective treatment for the diseases with advanced pharmaceutical products and surgical therapies is expected to substantiate the growth of the global opisthorchiasis treatment market in the future five years.
Increased awareness about the diseases and its available treatment further aids market growth. Although, lack of attention toward untreated waste dump in the oceans and other water bodies is also responsible for the increasing infectious instance and drives the global opisthorchiasis treatment market growth on the forecast years, until 2027.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Opisthorchiasis treatment Market"
https://www.techsciresearch.com/report/opisthorchiasis-treatment-market/8163.html
The global opisthorchiasis treatment market segmentation is based on type, diagnostic procedure, symptom, end user, regional distribution, and competitive landscape. Based on type, the market is divided between medications and surgery. Medication sub-segment is anticipated to hold the largest revenue shares of the market and dominate the segment in the upcoming five years.
The growth can be attributed to the increased product development for the better treatment and advancing pharmaceutical industry ensures the best possible healthcare service is provided. Medication is further sub-segmented into antibiotics, anthelmintics, and others. Antibiotics like Praziquantel, Albendazole, etc. have higher recovery rate as compared to other classes of drugs and thus anticipated to dominate the segmentation.
Surgical methods are often opted for the rare cases of Cholangiocarcinoma, where the malignant tumor can be surgically removed from the bile duct. In case Cholangiocarcinoma is detected at late stages, palliative treatment is done where bile is artificially drained out such that obtrusive jaundice symptoms can be controlled to an extent.
Based on diagnostic procedure, the market is further differentiated into cholangiography, MRI, ultrasonography, CT scan, and others. Cholangiography is anticipated to hold the largest revenue shares of the market and dominate the market segment in the next five years on the account of standardization of stool examination.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8163
Customers can also request for 10% free customization on this report.
Ultrasonography of the liver and gall bladder is conducted to identify an enlarged non-functioning gall bladder with sludge. CT scans are now utilized as an advanced diagnosis method instead of cholangiography to identify intrahepatic bile ducts with enlarged images, thus making diagnosis early and efficient.
Based on end user the market is again bifurcated into hospitals & clinics, ambulatory care centers, and others. Hospitals & clinics are anticipated to dominate the segment in the upcoming five years due to increasing instances of the patient. Hospitals and clinics have the availability of the better medical equipment, products, and services such that effective treatment can be provided to the patient.
Some of the market players, dominating the global market are:
- Cipla Inc.
- Johnson & Johnson
- Sun Pharmaceutical Industries Ltd.
- Merck KGaA
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- AbbVie Inc
- Mankind Pharma Limited
“Asia Pacific region is anticipated to hold the largest revenue shares of the market due to increasing instances of opisthorchiasis among the population in the future five years. Dependency of the population over seafood for consumption in raw form among the countries like Thailand, Vietnam, Korea, China, etc. is anticipated to further support the growth of the global opisthorchiasis treatment market in the next five years. Also, increased aquaculture practices for the products like seashells, seaweed, and pearls also substantiate the market growth in the region in upcoming five years. The patient count suffering from opisthorchiasis is also increasing in the European countries like Germany, Russia, Belarus, etc. is aiding to the growth of the market significantly in recent five years. Although, availability of the effective treatment and better medical facilities in the region further aid the market growth. New market players may focus on research and product development for the effective treatment and early diagnosis would help in future brand establishment. Future growth can also be achieved by merger and acquisitions with the global giants already established in the market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Opisthorchiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type (Medications {Antibiotics, Anthelmintics, Others} v/s Surgery), By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others), By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region”, has evaluated the future growth potential of global opisthorchiasis treatment and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global opisthorchiasis treatment market.
Browse Related Reports:
Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/over-the-counter-drugs-market/5054.html
Global Phobia Treatment Market By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others), By Treatment (Therapy {Desensitization, Flooding, Graded Exposures, Biofeedback} v/s Medication {Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others}), By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/phobia-treatment-market/7828.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
No comments:
Post a Comment